Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

被引:156
|
作者
Mainz, J. G. [1 ]
Naehrlich, L. [2 ]
Schien, M. [1 ]
Kaeding, M. [3 ]
Schiller, I. [1 ]
Mayr, S.
Schneider, G.
Wiedemann, B. [4 ]
Wiehlmann, L. [5 ]
Cramer, N. [5 ]
Pfister, W. [6 ]
Kahl, B. C. [7 ]
Beck, J. F. [1 ]
Tuemmler, B. [5 ]
机构
[1] Univ Hosp Jena, Dept Pediat, CF Ctr, Jena, Germany
[2] Univ Erlangen Nurnberg, Dept Pediat, CF Ctr, D-8520 Erlangen, Germany
[3] Chemnitz Hosp, CF Ctr, Chemnitz, Germany
[4] Univ Dresden, Dept Med Informat & Biometr, Dresden, Germany
[5] Hannover Med Sch, Klin Forschergrp, Hannover, Germany
[6] Univ Hosp Jena, Inst Med Microbiol, Jena, Germany
[7] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany
关键词
LUNG-TRANSPLANT RECIPIENTS; CLINICAL CHARACTERISTICS; COLONIZATION; BACTERIOLOGY; INFECTIONS; SINUSITIS; SURVIVAL; SINUSES;
D O I
10.1136/thx.2008.104711
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Lower airway (LAW) infection with Pseudomonas aeruginosa and Staphylococcus aureus is the leading cause of morbidity in cystic fibrosis (CF). The upper airways (UAW) were shown to be a gateway for acquisition of opportunistic bacteria and to act as a reservoir for them. Therefore, tools for UAW assessment within CF routine care require evaluation. Objectives: The aims of the study were non-invasive assessment of UAW and LAW microbial colonisation, and genotyping of P aeruginosa and S aureus strains from both segments. Methods: 182 patients with CF were evaluated (age 0.4-68 years, median 17 years). LAW specimens were preferably sampled as expectorated sputum and UAW specimens by nasal lavage. P aeruginosa and S aureus isolates were typed by informative single nucleotide polymorphisms (SNPs) or by spa typing, respectively. Results: Of the typable S aureus and P aeruginosa isolates from concomitant UAW- and LAW-positive specimens, 31 of 36 patients were carrying identical S aureus spa types and 23 of 24 patients identical P aeruginosa SNP genotypes in both compartments. Detection of S aureus or P aeruginosa in LAW specimens was associated with a 15- or 88-fold higher likelihood also to identify S aureus or P aeruginosa in a UAW specimen from the same patient. Conclusions: The presence of identical genotypes in UAW and LAW suggests that the UAW play a role as a reservoir of S aureus and P aeruginosa in CF. Nasal lavage appears to be suitable for non-invasive UAW sampling, but further longitudinal analyses and comparison with invasive methods are required. While UAW bacterial colonisation is typically not assessed in regular CF care, the data challenge the need to discuss diagnostic and therapeutic standards for this airway compartment. Trial registration number: NCT00266474.
引用
收藏
页码:535 / 540
页数:6
相关论文
共 50 条
  • [31] Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis
    Hubert, Dominique
    Reglier-Poupet, Helene
    Sermet-Gaudelus, Isabelle
    Ferroni, Agnes
    Le Bourgeois, Muriel
    Burgel, Pierre-Regis
    Serreau, Raphael
    Dusser, Daniel
    Poyart, Claire
    Coste, Joel
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (05) : 497 - 503
  • [32] Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients
    Ahlgren, Heather G.
    Benedetti, Andrea
    Landry, Jennifer S.
    Bernier, Joanie
    Matouk, Elias
    Radzioch, Danuta
    Lands, Larry C.
    Rousseau, Simon
    Nguyen, Dao
    BMC PULMONARY MEDICINE, 2015, 15
  • [33] Long-term coexistence of Pseudomonas aeruginosa and Staphylococcus aureus using an in vitro cystic fibrosis model
    Monteiro, Rosana
    Magalhaes, Andreia Patricia
    Pereira, Maria Olivia
    Sousa, Ana Margarida
    FUTURE MICROBIOLOGY, 2021, 16 (12) : 879 - 893
  • [34] Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients
    Finklea, James D.
    Hollaway, Rita
    Lowe, Karen
    Lee, Francesca
    Le, Jade
    Jain, Raksha
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (01) : 75 - 77
  • [35] Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus
    Buchs, Clelia
    Dalphin, Marie-Laure
    Sanchez, Stephane
    Perceval, Marie
    Coutier, Laurianne
    Mainguy, Catherine
    Kassai-Koupai, Behrouz
    Reix, Philippe
    EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (07) : 891 - 897
  • [36] Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients
    Hilliam, Y. K.
    Perry, A.
    Hall, A. J.
    Davison, J.
    Walton, K. E.
    Fothergill, J.
    De Soyza, A.
    Winstanley, C.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [37] Comparison of Three Molecular Techniques for Typing Pseudomonas aeruginosa Isolates in Sputum Samples from Patients with Cystic Fibrosis
    Kidd, Timothy J.
    Grimwood, Keith
    Ramsay, Kay A.
    Rainey, Paul B.
    Bell, Scott C.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (01) : 263 - 268
  • [38] Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients
    Fricks-Lima, J.
    Hendrickson, C. M.
    Allgaier, M.
    Zhuo, H.
    Wiener-Kronish, J. P.
    Lynch, S. V.
    Yang, K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (04) : 309 - 315
  • [39] Effect of Mutator P. aeruginosa on Antibiotic Resistance Acquisition and Respiratory Function in Cystic Fibrosis
    Ferroni, Agnes
    Guillemot, Didier
    Moumile, Kaoutar
    Bernede, Claire
    Le Bourgeois, Muriel
    Waernessyckle, Serge
    Descamps, Philippe
    Sermet-Gaudelus, Isabelle
    Lenoir, Gerard
    Berche, Patrick
    Taddei, Francois
    PEDIATRIC PULMONOLOGY, 2009, 44 (08) : 820 - 825
  • [40] Effect of continuous antistaphylococcal therapy on the rate of P-aeruginosa acquisition in patients with cystic fibrosis
    Ratjen, F
    Comes, G
    Paul, K
    Posselt, HG
    Wagner, TOF
    Harms, K
    PEDIATRIC PULMONOLOGY, 2001, 31 (01) : 13 - 16